Chong Yang, Rui Yokomori, Lee Hui Chua, Shi Hao Tan, Mun Yee Koh, Haruhito Totani, Takaomi Sanda, Toshio Suda. Deciphering the regulatory landscape of murine splenic response to anemic stress at single-cell resolution. Blood Advances. 2024. 8. 7. 1651-1666
Lu Wang, Tze King Tan, Hyoju Kim, Dennis Kappei, Shi Hao Tan, A. Thomas Look, Takaomi Sanda. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors. Cell Reports. 2023. 42. 12. 113541-113541
Jianbiao Zhou, Sabrina Hui Min Toh, Tze King Tan, Kalpnaa Balan, Jing Quan Lim, Tuan Zea Tan, Sinan Xiong, Yunlu Jia, Siok Bian Ng, Yanfen Peng, et al. Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma. Molecular Cancer. 2023. 22. 1
Hiroaki Hiramatsu, Rui Yokomori, Liu Shengyi, Norio Tanaka, Seiichi Mori, Kazuma Kiyotani, Osamu Gotoh, Shigeru Kusumoto, Nobuaki Nakano, Youko Suehiro, et al. Clinical landscape of TP73 structural variants in ATL patients. Leukemia. 2023
Fang Qi Lim, Allison Si Yu Chan, Rui Yokomori, Xiao Zi Huang, Madelaine Skolastika Theardy, Allen Eng Juh Yeoh, Shi Hao Tan, Takaomi Sanda. Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia. Haematologica. 2023. 108. 2. 367-381
Koshi Akahane, Zhaodong Li, Julia Etchin, Alla Berezovskaya, Evisa Gjini, Craig E. Masse, Wenyan Miao, Jennifer Rocnik, Rosana Kapeller, Jeremy R. Greenwood, et al. Anti-Leukemic Activity of the TYK2 Selective Inhibitor Ndi-031301 in T-Cell Acute Lymphoblastic Leukemia. BLOOD. 2016. 128. 22
Regina Wan Ju Wong, Phuong Thi Ngoc Cao, Wei Zhong Leong, Alice Wei Yee Yam, Tinghu Zhang, Shinsuke Iida, Takashi Okamoto, Ryuzo Ueda, Nathanael S. Grey, Takashi Ishida, et al. Identification of Super-Enhancer-Associated Cancer Genes Provides Novel Therapeutic Targets in Adult T-Cell Leukemia/Lymphoma. BLOOD. 2016. 128. 22
Koshi Akahane, Takaomi Sanda, Marc R. Mansour, Julia Etchin, Ng Cherry, David M. Weinstock, Anthony Letai, Daniel J. DeAngelo, A. Thomas Look. HSP90 Inhibition Has Potent Activity Against T-Cell Acute Lymphoblastic Leukemia (T-ALL) Through Degradation Of TYK2 Kinase. BLOOD. 2013. 122. 21
Takaomi Sanda, Ryuzo Ueda. Aberrant signal transductions in leukemia cell. Nippon rinsho. Japanese journal of clinical medicine. 2007. 65. 118-123
Hiroki Yano, Satoshi Kayukawa, Shinsuke Iida, Chiharu Nakagawa, Takaomi Sanda, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Atsushi Suzuki, Ryuzo Ueda. Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for refractory multiple myeloma. BLOOD. 2006. 108. 11. 366B-366B